We therefore propose that LPS may stimulate CD14 production in liver cells during the early stage of biliary atresia, promoting endotoxin removal, and that endotoxin signaling likely induces liver injury and impairs CD14 synthesis during the later stages. The gene discussed is CD14; the disease is biliary atresia.